{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T14:28:11Z","timestamp":1777386491544,"version":"3.51.4"},"reference-count":21,"publisher":"Georg Thieme Verlag KG","issue":"02","license":[{"start":{"date-parts":[[2021,10,7]],"date-time":"2021-10-07T00:00:00Z","timestamp":1633564800000},"content-version":"vor","delay-in-days":189,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aorta (Stamford)"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Patients with aortic incompetence frequently present with anatomical and pathological challenges such as elliptical dilated annulus, dilated aortic root, dilated ascending aorta, and with no calcification in the aortic cusps or annulus. Patients are commonly in graver clinical condition as a result of a long silent clinical course before overt congestive heart failure. All of the above make transcatheter therapies for native aortic valve regurgitation more challenging with poorer outcomes, escalating the risk of insufficient anchoring, prosthesis migration, and residual paravalvular leak compared with current transcatheter aortic valve replacement (TAVR) outcomes for aortic stenosis. There is a need for specialized TAVR devices to address this complex pathology. Surgical aortic valve replacement is the current treatment option and the gold standard for patients with aortic incompetence (AR). Currently, the specific off-label indication for TAVR in pure native AR could be a feasible and reasonable option, as a compassionate treatment is limited to inoperable patients and agreed on by the heart team.<\/jats:p>","DOI":"10.1055\/s-0041-1725122","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T21:01:52Z","timestamp":1633813312000},"page":"056-059","source":"Crossref","is-referenced-by-count":5,"title":["Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation: Challenging Pathology Awaiting Specialized Devices"],"prefix":"10.1055","volume":"09","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3414-8436","authenticated-orcid":false,"given":"Adam","family":"El-Gamel","sequence":"additional","affiliation":[{"name":"Cardiothoracic Unit, Waikato Hospital, Hamilton, New Zealand"},{"name":"Department of Surgery, The University of Auckland, Auckland, New Zealand"},{"name":"Medical Reseach Department, Waikato University, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2021,10,7]]},"reference":[{"issue":"17","key":"ref1","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery","volume":"363","author":"M B Leon","year":"2010","journal-title":"N Engl J Med"},{"issue":"23","key":"ref2","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa1103510","article-title":"Transcatheter versus surgical aortic-valve replacement in high-risk patients","volume":"364","author":"C R Smith","year":"2011","journal-title":"N Engl J Med"},{"issue":"17","key":"ref3","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"M B Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"01","key":"ref4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jtcvs.2014.05.014","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"148","author":"R A Nishimura","year":"2014","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"05","key":"ref5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1055\/s-0030-1271191","article-title":"Cardiac surgery in Germany during 2010: a report on behalf of the German Society for Thoracic and Cardiovascular Surgery","volume":"59","author":"J F Gummert","year":"2011","journal-title":"Thorac Cardiovasc Surg"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.4244\/EIJV9SSA11","article-title":"Native aortic valve regurgitation: transcatheter therapeutic options","volume":"9","author":"D Roy","year":"2013","journal-title":"EuroIntervention"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S134","DOI":"10.1161\/CIRCULATIONAHA.108.839787","article-title":"Survival in patients with severe aortic regurgitation and severe left ventricular dysfunction is improved by aortic valve replacement: results from a cohort of 166 patients with an ejection fraction < or =35%","volume":"120","author":"A R Kamath","year":"2009","journal-title":"Circulation"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.cpcardiol.2017.10.004","article-title":"Aortic valve regurgitation: a comprehensive review","volume":"43","author":"O A Akinseye","year":"2018","journal-title":"Curr Probl Cardiol"},{"issue":"11","key":"ref9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.20452\/pamw.1103","article-title":"Pathogenesis and pathophysiology of aortic valve stenosis in adults","volume":"121","author":"M Olszowska","year":"2011","journal-title":"Pol Arch Med Wewn"},{"issue":"07","key":"ref10","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/hrt.2004.042614","article-title":"Aortic regurgitation","volume":"92","author":"G Maurer","year":"2006","journal-title":"Heart"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jcin.2017.03.004","article-title":"Safety and efficacy of transcatheter aortic valve replacement in the treatment of pure aortic regurgitation in native valves and failing surgical bioprostheses: results from an international registry study","volume":"10","author":"F J Sawaya","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.athoracsur.2012.10.025","article-title":"Peak wall stress predicts expansion rate in descending thoracic aortic aneurysms","volume":"95","author":"E K Shang","year":"2013","journal-title":"Ann Thorac Surg"},{"issue":"15","key":"ref13","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jacc.2013.01.018","article-title":"Transcatheter aortic valve implantation for pure severe native aortic valve regurgitation","volume":"61","author":"D A Roy","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"06","key":"ref14","doi-asserted-by":"crossref","first-page":"739","DOI":"10.4244\/EIJV10I6A127","article-title":"CoreValve implantation for severe aortic regurgitation: a multicentre registry","volume":"10","author":"L Testa","year":"2014","journal-title":"EuroIntervention"},{"issue":"05","key":"ref15","first-page":"229","article-title":"Expansion of the indication of transcatheter aortic valve implantation--feasibility and outcome in \u201coff-label\u201d patients compared with \u201con-label\u201d patients","volume":"27","author":"C Frerker","year":"2015","journal-title":"J Invasive Cardiol"},{"issue":"22","key":"ref16","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1016\/j.jacc.2017.10.006","article-title":"Transcatheter aortic valve replacement in pure native aortic valve regurgitation","volume":"70","author":"S H Yoon","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"14","key":"ref17","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jcin.2015.08.015","article-title":"Expanding indications of transcatheter heart valve interventions","volume":"8","author":"F Praz","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"33","key":"ref18","first-page":"2578","article-title":"Feasibility trial reports deployment of new device for TAVI in aortic insufficiency","volume":"34","author":"A Tofield","year":"2013","journal-title":"Eur Heart J"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.4244\/EIJV9SSA17","article-title":"The Helio transcatheter aortic dock for patients with aortic regurgitation","volume":"9","author":"M Barbanti","year":"2013","journal-title":"EuroIntervention"},{"issue":"03","key":"ref20","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1093\/icvts\/ivu155","article-title":"Transcatheter aortic valve implantation of a second-generation valve for pure aortic regurgitation: procedural outcome, haemodynamic data and follow-up","volume":"19","author":"F Schlingloff","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"02","key":"ref21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1001\/jama.2014.7246","article-title":"Transcatheter aortic valve implantation in failed bioprosthetic surgical valves","volume":"312","author":"D Dvir","year":"2014","journal-title":"JAMA"}],"container-title":["AORTA"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1725122.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T16:48:56Z","timestamp":1725900536000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-0041-1725122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":21,"journal-issue":{"issue":"02","published-online":{"date-parts":[[2021,10,19]]},"published-print":{"date-parts":[[2021,4]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1725122","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2325-4637"],"issn-type":[{"value":"2325-4637","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4]]}}}